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Abstract
Bacterial virulence and antibiotic resistance have a significant influence on disease severity and treatment options during
bacterial infections. Frequently, the underlying genetic determinants are encoded on mobile genetic elements (MGEs). In
the leading human pathogen Staphylococcus aureus, MGEs that contain antibiotic resistance genes commonly do not
contain genes for virulence determinants. The phenol-soluble modulins (PSMs) are staphylococcal cytolytic toxins with a
crucial role in immune evasion. While all known PSMs are core genome-encoded, we here describe a previously unidentified
psm gene, psm-mec, within the staphylococcal methicillin resistance-encoding MGE SCCmec. PSM-mec was strongly
expressed in many strains and showed the physico-chemical, pro-inflammatory, and cytolytic characteristics typical of PSMs.
Notably, in an S. aureus strain with low production of core genome-encoded PSMs, expression of PSM-mec had a significant
impact on immune evasion and disease. In addition to providing high-level resistance to methicillin, acquisition of SCCmec
elements encoding PSM-mec by horizontal gene transfer may therefore contribute to staphylococcal virulence by
substituting for the lack of expression of core genome-encoded PSMs. Thus, our study reveals a previously unknown role of
methicillin resistance clusters in staphylococcal pathogenesis and shows that important virulence and antibiotic resistance
determinants may be combined in staphylococcal MGEs.
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Introduction
Staphylococci are ubiquitous colonizers of human epithelia and
frequent opportunistic pathogens involved in nosocomial infec-
tions [1]. In addition, the most virulent species, Staphylococcus aureus,
can cause severe disease such as septicemia, toxic shock syndrome,
and endocarditis, in both hospital and community settings [2].
The severity of a S. aureus infection is to a large extent
determined by the toxin repertoire of the infecting strain. For
example, S. aureus may produce toxic shock syndrome toxin-1 and
other superantigens (enterotoxins), leukocidins, a-toxin, and
phenol-soluble modulins (PSMs) [3,4]. Many of these molecules
destroy immune cells, thereby contributing considerably to the
immune evasion capacity of S. aureus. Some toxins, such as a-toxin
and the PSMs, are encoded on the bacterial core genome. Strain-
to-strain differences in the secretion of these toxins are mainly due
to differential gene expression [5–7]. In contrast, many other toxin
genes are located on mobile genetic elements (MGEs). While many
S. aureus strains produce MGE-encoded toxins, production of a
given MGE-encoded toxin is usually limited to a small number of
strains and strain-specific [8].
Staphylococcal infections are further complicated by frequent
and sometimes multiple antibiotic resistance [9]. After the wide
distribution of penicillinase-resistant strains in the middle of the
last century [10], methicillin became the antibiotic of first choice
for S. aureus infections. However, methicillin-resistant S. aureus
(MRSA) are now prevalent in hospitals [11]. In addition,
community-associated MRSA strains have emerged more recently
and are spreading globally [12]. Furthermore, methicillin
resistance is also common in coagulase-negative staphylococci
such as S. epidermidis (methicillin-resistant S. epidermidis, MRSE)
[13].
Antibiotic resistance genes are often located on MGEs such as
transposons, plasmids, or genomic islands [14]. Specifically, the
staphylococcal cassette chromosome mec (SCCmec) carries the mecA
gene responsible for resistance to methicillin. There are at least 4
main and several sub-types of SCCmec elements, ranging from 21
to 67 kb in size, which are characterized by the two essential mec
and ccr gene complexes and accessory gene loci such as
transposons [14]. Importantly, while toxins and other virulence
determinants are often encoded on MGEs, they have not been
found within SCCmec elements or on widespread staphylococcal
PLoS Pathogens | www.plospathogens.org 1 July 2009 | Volume 5 | Issue 7 | e1000533plasmids. Thus, acquisition of antibiotic resistance determinants
by horizontal gene transfer in staphylococci is usually not linked to
that of virulence factors [14].
PSMs are small, amphipathic and a-helical peptide toxins that
attract and activate neutrophils [7]. In addition, PSMs of the a-
type have pronounced capacity to lyse neutrophils and other cell
types. Highly virulent CA-MRSA produce large amounts of the
strongly cytolytic PSMa peptides, which are encoded in the core-
genome located psma operon and represent the main toxins
contributing to neutrophil lysis in these strains. Deletion mutants
in the psma operon have dramatically reduced capacity to cause
skin infections and bacteremia, indicating a crucial role of these
toxins in S. aureus pathogenesis [7].
Here we identified and characterized an a-type PSM peptide
that has pro-inflammatory and cytolytic activity and an important
role in S. aureus infection. In contrast to all PSMs found so far, the
newly identified psm-mec gene is encoded within an SCCmec MGE
rather than on the core genome, providing a molecular connection
between virulence and antibiotic resistance in staphylococci.
Results
Identification of the SCCmec-encoded PSM-mec
PSM peptides share physico-chemical properties rather than
amino acid sequence similarity [7,15,16]. Additionally, psm genes
are shorter than most cutoff thresholds for gene annotation.
Therefore, to identify and classify a peptide as a member of the
PSM family, initial detection and characterization of the peptide
by means such as reversed-phase HPLC/mass spectrometry (RP-
HPLC/MS), subsequent identification of the encoding gene, and
detection of PSM-typical features such as amphipathy and a-
helicity are required. Commonly, a given species produces a
characteristic pattern of PSM peptides due to the fact that psm
genes are encoded on the core genome rather than on MGEs
[7,15,16]. However, while screening collections of S. aureus and S.
epidermidis strains [17–21], we found that some strains showed an
additional peptide peak in the RP-HPLC profile within the elution
range characteristic for PSMs (shown for one S. epidermidis and one
S. aureus strain in Figure 1A). The molecular weight of the peptide,
2414.6 Da (Figure 1B), as calculated from the electrospray
ionization (ESI) mass spectrum obtained by RP-HPLC/ESI-MS,
was the same in all these strains.
In detail, we analyzed a collection representing a wide variety of
S. aureus strains [22], which contained 34 strains, 11 of which were
MRSA, 79 MRSA strains of pulsed-field types USA100, USA200,
USA300, USA500, USA1000, and USA1100 from infection and
carriage isolates from San Francisco [17,21], 54 infectious S.
epidermidis strains from Paris, 56% of which were MRSE [23], and
180 S. epidermidis strains from Norway, 29% of which were MRSE
[20]. Furthermore, we analyzed an S. epidermidis strain collection
from Shanghai [19] that included 51 colonizing strains (no MRSE)
and 41 isolates from infection (29% MRSE). 10% of all analyzed
MRSA and 68% of all analyzed MRSE strains produced the
peptide, while it was never detected in methicillin-sensitive S. aureus
(MSSA) or S. epidermidis (MSSE). Accordingly, in the Shanghai
collection, all producing S. epidermidis strains were isolated from
human infections, whereas the MSSE skin isolates (colonizers)
never produced the peptide (Figure 2). In the San Francisco strain
collection, the peptide was found in 5 of 14 infectious USA100 and
USA200 isolates, but never in other pulsed-field types. These
Figure 1. PSM-mec production in S. aureus and S. epidermidis. (A)
RP-HPLC elution profile of S. aureus MSA3407 and S. epidermidis RP62A
culture filtrates (at 8 h of growth). Equal volumes were applied to a C8
column and eluted with a 0.1% TFA water/acetonitrile gradient. PSM
peptides characteristically elute at very high acetonitrile concentrations.
Peaks of major PSM peptides and the newly identified PSM-mec are
indicated. (B) Electrospray ion chromatogram of the PSM-mec peak
obtained by RP/HPLC/ESI-MS (S. epidermidis RP62A). The respective
PSM-mec ESI chromatogram of S. aureus MSA3407 or any strain with
PSM-mec production showed the same m/z peaks. The series of peaks




The extreme danger associated with Staphylococcus aureus
infections is due to the combination of frequent antibiotic
resistance, which prevents efficient treatment, with ex-
traordinary virulence, which determines the severity of
disease. S. aureus is known to exchange antibiotic
resistance and virulence determinants between different
strains, thereby spreading the capacity to cause serious
infections in the S. aureus population. The genetic
information for these determinants is usually found on
so-called mobile genetic elements. It has been noted that
such exchangeable elements carry genes for either
virulence or antibiotic resistance, but not both. Here, we
identified and characterized a potent toxin, whose gene is
located within an element that encodes resistance to the
important antibiotic methicillin. The toxin had strong
capacity to kill human white and red blood cells and
significantly affected the capacity of MRSA to cause
disease. Our study shows that acquisition of methicillin
resistance may be combined with gaining possession of
potent toxins by a single event of genetic exchange, which
likely represents an important feature accelerating the
evolution of MRSA virulence.
SCCmec Phenol-Soluble Modulin
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SCCmec elements.
Next, we purified the peptide and determined the N-terminal
sequence, which allowed identification of the peptide-encoding
gene (Figure 3). Analysis of published staphylococcal genome
sequences revealed presence of the gene in the type II SCCmec
clusters of S. epidermidis strain RP62A [24], and S. aureus strains
Mu50, N315 and Sanger 252 [25,26] (Figure 3). In addition, a
tblastn search (www.ncbi.nlm.nih.gov/blast.cgi) showed that the
gene is present within SCCmec clusters of types II or III in a series
of staphylococcal strains including strains of S. aureus, S. epidermidis,
S. saprophyticus, S. pseudintermedius, and S. sciuri. Furthermore, we
typed the analyzed MRSE producers from the Paris and Shanghai
collections as predominantly of SCCmec type III (21/27) and the
four MRSA producers from the Fitzgerald et al. collection [22] as
SCCmec type II. Finally, we also detected the gene in MRSA
strains from Canada and New York City (strains C10682 and
BK20781, GenBank FJ390057 and FJ670542.1) that contain the
novel SCCmec type VIII, which appears to have arisen from
recombination between different SCCmec elements [27]. These
results indicated that the gene is typically encoded in SCCmec
elements, specifically in the J1 region that is common to SCCmec
types II and III (Figure 3) [14]. Thus, we termed the novel PSM
peptide PSM-mec owing to the fact that it is encoded within
SCCmec clusters. Furthermore, presence of the gene in SCCmec
types II and III is in accordance with the data obtained with
different MRSA pulsed field types, particularly the absence from
community-associated MRSA of pulsed-field type USA300, which
contain SCCmec type IV [28].
Like all psm genes [7,15,16], the psm-mec gene contained only the
DNA sequence encoding the final peptide product and no signal
peptide. In addition, comparison of the theoretical mass of the
translation product (2386.8 Da) with the detected mass of the
secreted peptide indicated formylation of the N-terminal methi-
onine (mass difference of 28 Da), which is common in bacterial
proteins and found in all PSMs [7,15,16]. Analysis of secondary
structure by circular dichroism (CD) (Figure 4A) and arrangement
of the peptide sequence in an a-helical wheel (Figure 4B) revealed
strong a-helicity and amphipathy, confirming that PSM-mec has
characteristics typical of PSM peptides.
Characteristics of PSM-mec production
All known PSM peptides are under control of the agr quorum-
sensing system [7,29]. Growth phase-dependent production of
PSM-mec followed the same pattern as observed for other PSMs
(Figure 5A), suggesting quorum-sensing control. Furthermore, the
agr-dysfunctional MRSA strains N315 and Mu50 have all psm
genes including psm-mec [26], but do not produce the correspond-
ing gene products (data not shown). Moreover, we never detected
PSM-mec in strains without d-toxin production, which is
indicative of a defective agr system. These observations suggested
Figure 2. Production levels of PSM-mec in S. epidermidis
infection and colonizing skin isolates. PSM-mec concentrations
(at 8 h of growth) in S. epidermidis isolates from a Shanghai strain
collection [19] obtained from the skin of healthy individuals without
recent exposure to hospitals, or from S. epidermidis infections (mainly
catheter-related, blood, and urinary tract infections) were determined
by RP-HPLC/ESI-MS. Determined concentrations of d-toxin in the strains
are shown in comparison.
doi:10.1371/journal.ppat.1000533.g002
Figure 3. Location of the psm-mec gene in SCCmec elements of types II and III. Type II and III SCCmec elements are shown on the top, based
on Genbank accession numbers D86934 (strain S. aureus N315, type II) and AB037671 (type III) [14]. The essential mec (methicillin resistance and
regulation) and ccr (recombinase) genes are shown in color, other accessory elements are in grey. The region that contains the psm-mec gene and the
overlapping fudoh locus [39] is magnified at the bottom. SD, Shine-Dalgarno sequence.
doi:10.1371/journal.ppat.1000533.g003
SCCmec Phenol-Soluble Modulin
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this hypothesis, we applied cross-inhibiting S. epidermidis autoindu-
cing peptide, an efficient and specific inhibitor of S. aureus agr [30],
to cultures of PSM-mec producing S. aureus. This led to complete
absence of all PSMs, including PSM-mec (Figure 5B). Thus, PSM-
mec production is under control by the quorum-sensing system agr
like other PSMs.
The psm genes are regulated by direct binding of the AgrA
response regulator to the psm promoter regions, distinguishing psm
from many other agr-regulated genes that are under control of the
regulatory RNA, RNAIII [31]. Analysis of the psm-mec promoter
regions in the published genomes did not reveal consensus binding
sites for AgrA (data not shown). However, as AgrA binding sites
are not always completely conserved [31], the exact mechanism of
psm-mec regulation by agr remains to be evaluated.
Notably, in many strains PSM-mec was produced at high levels,
approximately achieving or inone strainexceeding production levels
of the otherwise most abundant PSM, d-toxin (PSMc) (Figure 1, 2,
5C). Furthermore, while PSM-mec production was usually corre-
lated with that of other PSMs, some strains showed a different
production pattern. Strain MSA890 for example had high relative
production of PSM-mec compared to other PSMs (Figure 5C).
Thus, the fact that PSM-mec production is not always entirely
correlated with that of d-toxin indicates regulatory influences in
addition to agr, as previously shown for other PSMs [7,31].
Role of PSM-mec in inflammation and immune evasion
PSM peptides, particularly those of the a-type, cause chemo-
taxis, specific release of cytokines such as IL-8, and lysis of
neutrophils and erythrocytes [7]. To analyze whether PSM-mec,
which by its size and physico-chemical characteristics forms part of
the PSM a-type family, has similar pro-inflammatory and lytic
capacities, we first determined chemotaxis and calcium flux in
human neutrophils. PSM-mec had lower chemotactic activities
(Figure 6A) and elicited lower calcium flux (Figure 6B) than the
most potent PSMa3, but in a range similar to that detected for
other a-type PSMs and in general higher than that of b-type
PSMs. Then, we determined the capacity of PSM-mec to activate
human neutrophils by measuring surface exposure of gp91phox
and CD11b (Figure 6C, 6D). Capacity of PSM-mec to activate
human neutrophils was lower than that of the most potent
PSMa3, but in the range of the other a-type PSMs and d-toxin,
and higher than that of b-type PSMs. The capacity of PSM-mec to
elicit production of the cytokine IL-8 was somewhat higher than
that detected for other a-type PSMs, but about in the same range
(Figure 6E). Neutrophil lysis as likely the most crucial immune
evasion property of PSMs was lower in PSM-mec than in other a-
type PSMs. However, at 50 mg/ml, neutrophil lysis by PSM-mec
obtained approximately the same level (Figure 6F) as observed
previously for other a-type PSMs at 10 mg/ml [7]. Of note, these
concentrations are typically achieved by many strains in vitro [7]
(Figures 2, 5), indicating that the contribution of PSM-mec to
overall cytolytic capacity of PSM-mec producing strains achieves
that of PSMa peptides. Finally, lysis of sheep erythrocytes by
PSM-mec was in an intermediate range compared to other PSMs
(Figure 6G). Overall, these results demonstrate that PSM-mec has
pro-inflammatory capacities similar to other a-type PSMs,
although not as pronounced as for the most potent PSMa3.
Role of the cysteine residue in PSM-mec
In contrast to all other PSM peptides identified until now, PSM-
mec has one cysteine residue, which in secreted peptides usually
indicates dimerization. To evaluate whether PSM-mec is present
as a dimer and needs dimerization for its biological function, we
synthesized mutant peptides with alanine and serine substitutions
for the cysteine residue at position 17 of PSM-mec (PSM-mec
C17A, PSM-mec C17S) (Figure 3). We first used size exclusion
chromatography (SEC)/ESI-MS of PSM-mec C17A, PSM-mec
C17S, and unreduced and reduced versions of PSM-mec to
investigate whether PSM-mec is present as a dimer in its natural
form. All peptides eluted at the same retention time (Figure 7).
Furthermore, masses of the isolated and reduced versions of PSM-
mec were the same and no peaks were obtained when calculating
extracted ion chromatograms (EICs) with the mass of the
theoretical oxidized, dimeric PSM-mec (Figure 7). Finally, EICs
of S. aureus and S. epidermidis supernatants only showed the
monomeric PSM-mec. These results indicate that PSM-mec does
not dimerize despite the single cysteine in its amino acid sequence.
Figure 4. Physico-chemical characteristics of PSM-mec. (A) CD spectrum. Computation of a-helical content gave the following results: 59.3%
(CONTINLL), 56.2% (SELCON3), 63.7% (CDSSTR). (B) Arrangement of PSM-mec (positions 2–19) in an a-helical wheel showing the amphipathy that is
typical for PSMs: a hydrophilic side (left) and hydrophobic side (right).
doi:10.1371/journal.ppat.1000533.g004
SCCmec Phenol-Soluble Modulin
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the biological function of PSM-mec, focusing on IL-8 secretion and
neutrophil lysis. Substitution with alanine or serine only led to
slightly reduced capacityto elicit production of IL-8 and lyse human
neutrophils. Neutrophil lysis and IL-8 secretion were impaired to a
more pronounced extent when the cysteine residue was replaced by
serine than alanine, which is likely due to the fact that the cysteine
residue is placed within the hydrophobic side of the amphipathic a-
helix (Figure 4) and the hydroxyl side chain of serine may interfere
with the amphipathic arrangement of the PSM-mec a-helix. These
results indicated that the role of the cysteine residue in PSM-mec is
likely limited to contributing to the PSM-mec a-helical structure
and the cysteine sulfhydryl group does not have an additional
specific function such as in peptide dimerization.
PSM-mec has a limited impact on biofilm formation and
intercellular aggregation
PSM peptides have been suggested to impact biofilm formation
based on their detergent-like structure that indicates surfactant
capacities [32,33]. To analyze whether PSM-mec influences
biofilm development in S. aureus, we determined in vitro biofilm
formation on microtiter plates. First, we added synthetic PSM-mec
to the biofilm-positive, agr-negative strain SA113, which lacks PSM
production (data not shown). We measured the impact of PSM-
mec on biofilm formation directly on plastic and on fibrinogen-
precoated plates, to mimic both possible mechanisms of attach-
ment to indwelling medical devices [34] (Figure 8A). In both cases,
there was reduced biofilm formation at intermediate PSM-mec
concentrations (50 mg/ml), which corresponds to the range of
PSM-mec production in bacterial culture filtrates. It is possible
that the lack of biofilm-inhibiting activity at higher concentrations
is due to peptide aggregation. Aggregation into micelle-like multi-
molecular clusters in a concentration-dependent fashion has been
described for the PSM d-toxin [35].
To analyze the biological role of PSM-mec in vivo, we focused on
S.aureusowing toits greater importance asa pathogen. Weproduced
isogenic mutants by allelic replacement of the psm-mec gene in strains
S. aureus Sanger 252 and the four MRSA strains from the analyzed S.
aureus strain collection that showed PSM-mec production (MSA820,
MSA890, MSA1601, MSA3407). Then, we compared the isogenic
psm-mec deletion mutants with the corresponding wild-type strains.
There wereslight,yet significant influencesonbiofilmformation and
intercellular aggregation in some strains (Figure 8B, 8C). Together,
these results indicate that PSM-mec has a small concentration-
dependent capacity to impact adhesion to surfaces, biofilm
formation, and intercellular aggregation.
PSM-mec contributes to pathogenesis
To investigate whether PSM-mec has a role in pathogenesis, we
first analyzed neutrophil lysis caused by culture filtrates of the
isogenic psm-mec deletion mutant strains compared to those of the
correspondingwild-typestrains.Wedetected significantlydecreased
capacityto lyse human neutrophils inthe psm-mecdeletionmutant of
strain MSA890, but not in the other deletion strains (Figure 9A).
Most likely, this is due to the fact that strain MSA890 produces
considerably more relative amounts of PSM-mec, compared to
core-genome encoded PSMs, than the other strains (Figure 5C).
Addition of increasing concentrations of PSM-mec to culture
filtrates of the MSA890 psm-mec deletion strain, up to 100% of that
detected in the wild-type strain under corresponding growth
conditions, completely restored the neutrophil-lytic capacity of the
MSA890 wild-type strain (Figure 9B), ruling out the possibility that
the observed phenotype was due to unintended second site
mutations. Furthermore, pronounced synergistic hemolysis of strain
MSA890,aphenotypecausedbyconcertedactivityofd-toxin,other
PSM or PSM-like peptides and a-toxin or b-toxin [36,37], was
considerably reduced by deleting the psm-mec gene in MSA890,
whereas no marked reduction was detected in the other isogenic
Figure 5. Characteristics of PSM-mec production and regula-
tion in S. aureus. (A) Production of d-toxin and PSM-mec during
growth in shaken culture. (B) PSM production in strain S. aureus MSA890
with and without addition of agr-inhibiting S. epidermidis autoinducing
peptide [30,52]. With addition of inhibitor, no PSMs were detectable. (C)
Production of selected PSMs at 8 h of growth in the PSM-mec
producing S. aureus Sanger 252 and other MRSA strains [22].
doi:10.1371/journal.ppat.1000533.g005
SCCmec Phenol-Soluble Modulin
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production can substitute for the lack of cytolytic capacity in strains
such as MSA890, in which expression of genome-encoded cytolytic
PSMs is low. Notably, this includes lysis of human neutrophils as
likely the most crucial function of PSMs in pathogenesis.
To analyze whether psm-mec impacts pathogenesis in important
manifestations of S. aureus disease, we performed murine
bacteremia and skin infection models. We have previously shown
in these models that deletion of the strongly cytolytic a-type PSMs
encoded on the psma operon leads to greatly decreased potential of
Figure 6. Pro-inflammatory and cytolytic capacities of PSM-mec and derivatives. (A) Chemotaxis of human neutrophils. Peptides were
applied at 0.5 mg/ml (PSMa3), 2 mg/ml (d-toxin), 5 mg/ml (PSM-mec), and 10 mg/ml (PSMb1). (B) Calcium flux in human neutrophils. Peptides were
applied at 0.1 mg/ml (PSMa3), 1 mg/ml (d-toxin, PSM-mec), and 2.5 mg/ml (PSMb1). In (A) and (B), values were corrected for the different
concentrations applied. (C,D) Surface expression of CD11b and gp91phox on human neutrophils. #, lysis of neutrophils occurred. For PSMs, bars
represent values obtained from increasing concentrations of peptide: 10, 100, 200, 400, 1000, 10000 ng/ml, from left to right in each group. (E)
Secretion of the cytokine IL-8 at 10 mg/ml of PSM. (F) Neutrophil lysis at 50 mg/ml of PSM, comparison of PSM-mec with C17A and C17S replacement
peptides. (G) Hemolytic activity. (H) Secretion of IL-8, comparison of PSM-mec with with C17A and C17S replacement peptides. (G,H) PSM peptides
were applied at 10 mg/ml. (F,H) Statistical comparisons are vs. PSM-mec. *, p,0.05; **,p,0.01; N.S., not significant. In (A,B,C,D,E, and G) values for
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deletion mutant pairs of strains S. aureus MSA890 and Sanger 252,
the latter as an example of the strains in which there was no
change in cytolytic activity between psm-mec deletion and wild-type
strains. With MSA890 and MSA890Dpsm-mec, we detected very
significant differences in lesion size and weight loss in the skin
infection model (Figure 10A–C) and in animal survival rates in the
bacteremia model (Figure 10D). In contrast, there were no
significant differences between strains S. aureus Sanger 252 and
Sanger 252Dpsm-mec in the same models (data not shown). These
results are in accordance with those achieved in the neutrophil
lysis and hemolysis assays, indicating that the presence of PSM-
mec may significantly impact S. aureus pathogenesis when PSM-
mec levels exceed those of other cytolytic PSMs.
Discussion
In this study, we identified a pro-inflammatory and cytolytic
PSM peptide, PSM-mec, that is genetically linked to methicillin
resistance, thus providing a molecular connection between two key
traits determining the outcome of S. aureus disease. Our results
indicate that acquisition of SCCmec elements encoding PSM-mec
by horizontal gene transfer may significantly alter the capacity of
S. aureus and potentially other staphylococci to cause disease, in
addition to their established role in conferring resistance to
methicillin. This represents a previously unknown example of
toxin hitchhiking on staphylococcal mobile genetic elements
primarily in charge of transferring antibiotic resistance.
While expression of the PSM-mec peptide did not significantly
alter disease progression in a strain that produces high relative and
absolute amounts of other cytolytic PSMs, PSM-mec had a very
significant impact when other PSMs were only expressed at low
levels, indicating that acquisition of psm-mec-encoding SCCmec
elements may substitute for low level PSM expression in the
recipient strain. Whereas PSM-mec expression is under control of
agr as all other PSM peptides, additional regulatory factors are
likely responsible for the high relative production of PSM-mec
observed in strains such as S. aureus MSA890.
Using large strain collections, we did not detect PSM peptides
other than PSM-mec and the previously described core genome-
encoded PSMs. Therefore, PSM-mec is likely the only MGE-
encoded staphylococcal PSM. The frequency of PSM-mec
production was high in MRSE and considerable in MRSA of
pulsed-field types USA100 and USA200, which represent the most
common types associated with hospital infections [38].
Kaito et al. recently described an open reading frame called
‘‘fudoh’’ that is reportedly involved incolony spreading andvirulence
[39]. The 59 end of fudoh overlaps to a large extent with the psm-mec
gene, which is transcribed in opposite direction to fudoh (Figure 4).
However, in contrast to psm-mec, there is no evidence for expression
of fudoh. In addition, the fudoh gene does not have a Shine-Dalgarno
sequence indicating a fudoh protein product is made. Possibly, the
phenotypes attributed to fudoh by Kaito et al. [39] may thus have
been due, at least in part, to interference with the psm-mec locus.
Nevertheless, our results and those by Kaito et al. both emphasize
the importance of the fudoh/psm-mec locus in S. aureus pathogenesis.
Finally, identification of PSM-mec may explain reports on a
short-chain teichoic acid with pro-inflammatory properties
described in S. epidermidis and termed ‘‘lipid S’’ [40]. The
identification of ‘‘lipid S’’ as such was based on an electrospray
mass spectrogram that showed exactly the same two m/z peaks as
PSM-mec [40]. In contrast, it did not show the series of equidistant
Figure 7. Analysis of PSM-mec dimerization by size exclusion chromatography/mass spectrometry (SEC/ESI-MS). Samples of synthetic
PSMs and PSM-mec containing S. aureus or S. epidermidis culture filtrates, with or without reduction performed with 3% mercaptoethanol for 2 h at
room temperature, were run on a Superdex HR 10/30 column with isocratic elution using 0.1% TFA/30% acetonitrile. Acid conditions in the elution
buffer ascertain stability of the reduced or oxidized status during chromatography. The graphic shows the extracted ion chromatograms (EICs) of the
main, double charged ions of the electrospray mass spectra of PSM-mec before and after reduction. No peaks were obtained when plotting EICs for a
mass loss of 2 Da (1206.4 Da), as expected for dimeric, oxidized PSM-mec. In addition, extracted ion chromatograms of the alanine and serine
subsitution peptides are shown (only one form owing to the absence of an oxidizable cysteine).
doi:10.1371/journal.ppat.1000533.g007
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It is thus likely that the mass spectrograms leading to the
description of ‘‘lipid S’’ were misinterpreted and the extracts
contained PSM-mec. This would also explain a later report on
pro-inflammatory capacities of ‘‘lipid S’’ [41].
In conclusion, our study shows that in contrast to previous belief,
staphylococci may bundle resistance and virulence factors on mobile
genetic elements, thus combining the transfer of two important
determinants for causing human disease in one geneticexchange event.
Materials and Methods
Ethics statement
All animals protocols were reviewed and approved by the
Animal Use Committee at Rocky Mountain Laboratories, NIAID,
NIH. Human neutrophils were obtained from healthy volunteers
in accordance with protocols approved by the Institutional Review
Board for Human Subjects, NIAID, and the University of
Tu ¨bingen, Germany.
Strains and growth conditions
S. aureus and S. epidermidis genome sequencing strains (S.
epidermidis RP62A and ATCC12228, S. aureus COL, Sanger 252,
Sanger 476, N315, Mu50, USA300, and MW2) were acquired
from the Network on Antimicrobial Resistance in S. aureus
(NARSA). Other MRSE and MSSE S. epidermidis strains were
from Shanghai (,100 strains), Paris (,70), and Norway (,100)
[18–20], and other S. aureus strains were from a San Francisco
strain collection (,80, all MRSA) in addition to those published by
Fitzgerald et al. (,35, MRSA and MSSA) [17,21,22]. All strains
were grown in tryptic soy broth (TSB). When necessary during
cloning of the allelic replacement plasmid, antibiotics were added
at appropriate concentrations (ampicillin at 100 mg/ml for cloning
in E.coli; chloramphenicol at 10 mg/ml for staphylococci). For
strains for which information on methicillin resistance was not
available from the literature, methicillin resistance was determined
by plating on TSB agar containing 6 mg/ml oxacillin.
Deletion of psm-mec
Allelic replacement of the psm-mec gene was performed using the
procedure described by Bae and Schneewind [42] which allows for
gene deletion without replacement by an antibiotic resistance
cassette. Using this procedure, the psm-mec gene was deleted in its
entirety. Briefly, 2 PCR fragments up- and downstream of psm-mec,
introducing att1 and att2 recombination sites at the distal ends and
anEcoRIsiteatthepsm-mecendswereamplifiedfromgenomicDNA
of S. aureus Sanger 252. Oligonucleotides used were PSMErev1
(caagacttgcattcaggctttcggtgaattctttc), PSMEatt1 (ggggacaagtttgta-
caaaaaagcaggctggaagttttgtgctttataatgaacgggagcaagc), PSMErev2
(caccagtgaattccatatgcataccctctttc), and PSMEatt2 (ggggaccactttgta-
caagaaagctgggtgtaccacctagcaaagttgcaaatttgac).
After digestion with EcoRI and ligation, the resulting fragment
with flanking att1 and att2 sites was cloned into plasmid pKOR1
[42] using att recombination and a Clonase kit (Invitrogen). The
resulting plasmid was electroporated in S. aureus RN4220, isolated
from this strain and electroporated in the target strain. Afterwards,
the allelic recombination procedure was performed as described
[42]. Fidelity of gene deletion was determined by analytical PCR
and RP-HPLC/ESI-MS. The PSM production phenotype of all
deletion and wild-type strains was verified regularly and in all pre-
cultures grown for key experiments using RP-HPLC/ESI-MS. This
is important to rule out spontaneous mutation in the agr system,
which happens frequently [43] and owing to agr control of all PSMs
[7,29,31] may lead to strains completely devoid of PSM production.
Figure 8. Influence of PSM-mec on biofilm formation and
intercellular aggregation. (A) Impact of increasing concentrations of
synthetic PSM-mec on biofilm formation using uncoated and fibrino-
gen-precoated polystyrene microtiter plates. PSM-negative S. aureus
SA113 was used as indicator biofilm-forming strain. (B) Biofilm
formation by S. aureus PSM-mec producers in comparison to isogenic
psm-mec deletion mutants. (C) Aggregation phenotype of S. aureus
MSA890 and isogenic psm-mec deletion mutant during mid-exponential
growth phase (3 h) in shaken TSB flasks. Note that these are the same
conditions as used to inoculate animals, in which owing to the
aggregation phenotype, qRT-PCR and OD rather than CFU measure-
ments were used to guarantee equal inocula. Differences in aggrega-
tion of the other isogenic strain pairs were similar or less pronounced.
doi:10.1371/journal.ppat.1000533.g008
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Typing of S. epidermidis and S. aureus SCCmec was performed
using the method by Kondo et al. [44].
Peptide synthesis
Peptides were synthesized by commercial vendors with an N-
terminal formyl methionine residue in each peptide. Peptide
sequence fidelity was determined by the Peptide Synthesis Unit of
the NIAID.
Circular dichroism (CD) measurement
The structures of synthetic PSM peptides were analyzed by CD
spectroscopy on a Jasco spectropolarimeter model J-720 instru-
ment. Solutions of PSM peptides, at 1.0 mg/ml, were prepared in
50% trifluoroethanol. Measurements were performed in triplicate
and the resulting scans were averaged, smoothed, and the buffer
signal was subtracted.
Chromatography/mass spectrometry
RP-HPLC/ESI-MS was performed on an Agilent 1100
chromatography system coupled to a Trap SL mass spectrometer
using a Zorbax SB-C8 2.3630 mm column as described [29].
Quantification was performed by integration of the UV spectra, if
peaks were well separated. Alternatively, quantification was based
on extracted ion chromatograms using the most abundant peaks of
the electrospray ion mass spectra of the respective PSM peptides,
with calibration using synthetic peptides, as described [29]. SEC/
ESI-MS was performed using the same equipment as RP-HPLC/
ESI-MS with a Superdex Peptide HR 10/30 column (GE
Healthcare) applying an isocratic gradient of 0.1% trifluoroacetic
acid in 30% acetonitrile at 0.5 ml/min.
PSM-mec purification and N-terminal sequencing
PSM-mec was purified from S. epidermidis RP62A stationary phase
c u l t u r eu s i n gt h es a m ep r o c e d u r ea su s e dp r e v i o u s l yf o rt h el a r g e - s c a l e
isolation of other PSMs [16]. Briefly, supernatant was precipitated
using 10% ice-cold trichloroacetic acid. The pellet was dissolved in
100 mM Tris buffer pH 8.0 and taken to neutral pH with 6 N
NaOH. Then, a 2-step reversed-phase chromatography protocol was
used for purification as described [16]. For N-terminal sequencing at
the Peptide Sequencing Unit of the NIAID, the N-terminal formyl
group was removed by heating for 2 h at 55uC as described [45].
Figure 9. Cytolytic activities of S. aureus PSM-mec producers and isogenic psm-mec deletion mutants. (A) Lysis of human neutrophils. Culture
filtrates ofstrains were mixed withhuman neutrophils at a 1:10 dilution and lysis was measured after 1 h by release oflactatedehydrogenase(LDH).Values
are means6SEM obtained from neutrophils of 5 independent donors. *, p=0.02 vs. wild-type. Differences between values for other wild-type and isogenic
psm-mec deletion strains were not statistically significant. (B) Lysis of human neutrophils, complementation with PSM-mec. PSM-mec was added to culture
filtrates of the psm-mec deletion strain in increasing concentrations (10, 20, 50, and 100% of the concentration detected in the wild-type strain).
Experimentalconditionswerethesameasin(A).Valuesaremeans6SEMobtained from neutrophils of 2 to4 independent donors. (C)Synergistic hemolysis.
Strains were grown for 24 h on sheep blood agar plates. Arrows mark different zones of synergistic hemolysis in strains S. aureus MSA890 and its isogenic
psm-mecdeletionmutant.(A,B)252,S.aureusSanger 252; 820, S. aureus MSA820; 890, S. aureus MSA890; 1601, S.aureusMSA1601;3407,S. aureus MSA3407.
doi:10.1371/journal.ppat.1000533.g009
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Semi-quantitative biofilm assays using polystyrene microtiter
plates and safranin staining were performed as described [46]. To
assess the impact of PSM-mec on biofilm formation, the peptide
was added at the time of inoculation with the indicator strain
SA113 from pre-cultures (1:100) at different concentrations. For
pre-coating with fibrinogen, a 25 mg/l fibrinogen solution in
phosphate-buffered saline (PBS) was filter-sterilized and 100 ml
solution were pipetted in each well. After 18 h at 4uC, wells were
washed twice with PBS, blocked with 2% sterile bovine serum
albumin (BSA) solution for 2 h at 37uC, and washed 4 times with
PBS. Then the biofilm assay was performed as described [46].
Human neutrophil isolation
PMNs were isolated from venous blood of healthy volunteers as
described [47,48].
Neutrophil chemotaxis and calcium ion fluxes
Neutrophils were subjected to a brief hypotonic shock with
pyrogen-free water (Sigma), washed, and suspended at 5610
6
cells/ml in HBSS containing 0.05% human serum albumin (HSA)
(CLB). Chemotaxis of neutrophils was determined by using
fluorescently-labeled neutrophils that migrated through a mem-
brane fitted into an insert of a 24-well microtiter plate transwell
system (Costar) containing a prewetted 3-mm-pore-size polycar-
bonate filter as described [47]. For measurement of calcium ion
fluxes, 5610
6 neutrophils/ml were loaded with 2 mM Fluo-3-AM
(Molecular Probes) in RPMI containing 0.05% HSA (RPMI-HSA)
for 20 min at room temperature under agitation, washed twice
with buffer, and resuspended in RPMI-HSA at 10
6 cells/ml.
Calcium fluxes were analyzed with a FACScalibur (Becton
Dickinson).
Priming of human neutrophils
Priming of PMNs by synthetic PSMs was determined by
increased surface expression of CD11b and gp91phox (granule
exocytosis). PMNs were incubated with 10–10000 ng/ml PSMs in
96-well tissue culture plates at 37uC with rotation for 60 min. The
assay was terminated by centrifuging cells at 4uC for 8 min at
3506g. Cells were washed twice in cold Dulbecco’s phosphate-
buffered saline and stained with and isotype control antibody (BD
Biosciences) or those specific for CD11b (mAb 44, BD Biosciences)
or gp91phox (mAb 7D5 [49]). Propidium iodide (0.5 mg/ml) was
used to identify dead cells. PMNs were analyzed on a
FACSCalibur flow cytometer (Becton Dickinson) and dead cells
were excluded with a single gate. Percent positive neutrophils were
determined with a marker defined by the boundary of the isotype-
matched control antibody.
Lysis of human neutrophils
Lysis of PMNs by synthetic PSMs or clarified S. aureus culture
media was determined essentially as described [48,50]. Synthetic
PSMs (10 or 50 mg/ml) were added to wells of a 96-well tissue
culture plate containing 10
6 PMNs and plates were incubated at
37uC for up to 3 h. At the desired times, PMN lysis was
determined by release of lactate dehydrogenase (LDH) (Cytotox-
icity Detection Kit, Roche Applied Sciences). Alternatively, wild-
type and isogenic mutant S. aureus strains were cultured for 24 h at
37uC in 50 ml TSB with shaking using a 100 ml flask. Bacteria
were removed by centrifugation and culture media were sterilized
by filtration and stored at 280uC in aliquots until used. Culture
medium (diluted 1:10) was mixed with human PMNs (10
6) and
tested for its ability to cause PMN lysis.
Figure 10. Impact of PSM-mec on virulence in animal infection
models. (A–C) Mouse skin abscess model. Crl: SKH1-hrBR hairless mice
were injected subcutaneously with 1610
7 CFUs/50 ml. Animal weights
and skin lesion dimensions were examined at 24-h intervals for a total
of 14 days. Number of mice: wild-type strain MSA890, 9; psm-mec
deletion strain, 15, PBS control, 5. (A) Typical experimental outcome.
Skin lesions developed in mice infected with the wild-type strain, while
mice infected with the psm-mec deletion strain sometimes developed
swelling/mild abscess formation at the infection site, but never lesions.
Control mice injected with PBS showed no reaction. (B) Skin lesion sizes
over time. (C) Animal weights over time. *, p,0.05; **, p,0.01, for mice
infected with the wild-type strain compared to both other groups. (D)
Mouse bacteremia model. CD1 Swiss female mice were injected with
1610
8 CFUs/100 ml and disease advancement was measured every 3 h
for the first 24 h, then every 8 h for up to 72 h. Number of mice: wild-
type strain MSA890, 15; psm-mec deletion strain, 15, PBS control, 5.
doi:10.1371/journal.ppat.1000533.g010
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Measurement of IL-8 production in human neutrophils was
performed as described with a commercial ELISA assay kit (R&D
systems) according to the manufacturer’s instructions [7].
Hemolysis
Hemolytic activity of PSM peptides was determined by
incubating samples with a 2% (v/v) sheep red blood cells and
incubation for 1 h at 37uC as described [7]. Hemolytic activity of
S. aureus wild-type and psm-mec deletion strains was assessed by
streaking on sheep blood agar plates.
Mouse bacteremia and skin abscess models
Bacteremia and skin abscess models were performed as
described [7]. Briefly, mice were between 4 and 6 weeks of age
at the time of use. Mice were inoculated with S. aureus from mid-
exponential growth phase (3 h) at ,1610
8 CFUs/100 ml
(bacteremia model) or ,1610
7 CFUs/50 ml (abscess model) as
described [48]. As strains showed different aggregation leading to
different CFU, optical density was used to compare cell numbers
and injection of equal cell numbers was verified by quantitative
RT-PCR using the gyrB gene as described [51]. Control animals
received sterile saline only.
For the bacteremia model, health and disease advancement of
CD1 Swiss female mice were monitored every 3 h for the first
24 h, then every 8 h for up to 72 h. Animals were euthanized
immediately if showing signs of respiratory distress, mobility loss,
or inability to eat and drink. All surviving animals were euthanized
at 72 hours.
For the abscess model, Crl: SKH1-hrBR hairless mice were
examined for skin lesions and weight at 24-h intervals for a total of
14 days. Skin lesion dimensions were measured daily with a
caliper. Length (L) and width (W) values were applied to calculate
the area of lesions using the formula of L 6W. All animals were
euthanized after completion of the entire procedure.
Statistics
Statistical analysis was performed using Student’s t-tests for 2, or
1-way-ANOVA with Bonferroni post-tests for more than 2 groups,
and Graph Pad Prism version 5 software.
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